Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Arcosa ( (ACA) ) just unveiled an announcement.
On June 17, 2025, Arcosa, Inc. amended its existing credit agreement to establish a new class of term loans totaling $698,250,000. This refinancing effort allows Arcosa to prepay its previous term loan and offers a slightly reduced interest rate, enhancing its financial flexibility. The amendment includes provisions for prepayment premiums within six months if certain conditions are met, but otherwise allows prepayment without penalty.
The most recent analyst rating on (ACA) stock is a Buy with a $105.00 price target. To see the full list of analyst forecasts on Arcosa stock, see the ACA Stock Forecast page.
Spark’s Take on ACA Stock
According to Spark, TipRanks’ AI Analyst, ACA is a Outperform.
Arcosa’s overall stock score reflects strong financial performance and a positive outlook from the recent earnings call, which are tempered by a high valuation and mixed technical indicators. The company’s ability to manage profitability pressures and successful integration of acquisitions are significant strengths. However, the high P/E ratio and low dividend yield suggest valuation concerns, and technical analysis indicates a neutral trend.
To see Spark’s full report on ACA stock, click here.
More about Arcosa
Average Trading Volume: 286,014
Technical Sentiment Signal: Buy
Current Market Cap: $4.18B
See more data about ACA stock on TipRanks’ Stock Analysis page.